Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (1997)	7/13/1998 10:15:00 PM
From: Exacctnt	Read Replies (1) \| Respond to of 2553

Bob, I know what you mean about the biotechs lately. My immediate concern is Friday's expiration of GENZL $5 calls. I would like to milk out another two or three bucks by then, but may have to settle for breakeven. Then in August, I have some LGND $12.50 calls to deal with. Anticipation for street recognition of Ligand's promise caused me to buy more LGNDW today. One day, I hope soon, that baby is going to take off. If I had used M Burke's thirds strategy, I think I'm probably up to six thirds by now. <g> Regards, Bob